Shingo Hatakeyama

126PUBLICATIONS
112CO-AUTHORS
PharmacogenomicsPredictive and prognostic markersMolecular targetsNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (126)

|Jul 03, 2026
Real-world trends in anti-androgen prescribing and associated costs for prostate cancer in Japan: a nationwide analysis.

|May 31, 2026
Visualizing eligibility gaps between muscle-invasive bladder cancer trials and real-world patients.

|May 26, 2026
Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Study.

|Apr 07, 2026
Real-World Outcomes After Radical Cystectomy for Muscle-Invasive Bladder Cancer in Japan: A Nationwide Descriptive Study From the National Clinical Database.

Shingo Hatakeyama, Kyoko Yamamoto, Hiroyuki Yamamoto

|Mar 23, 2026
Association of Prophylactic Intravenous Corticosteroid Premedication With Toxicity and Survival in Patients Receiving Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma.

Masanao Shinohara, Hayato Yamamoto, Yohei Kawashima

|Mar 08, 2026
Overactive Bladder Symptoms as a Predictor of Longitudinal Decline in Grip Strength in Community-Dwelling Men: A 4-Year Longitudinal Study.

Hiroyuki Sato, Teppei Okamoto, Tomoko Hamaya

Pageof 21

Frequent Collaborators

17 joint publications

Naoki Fujita

12 joint publications

Tohru Yoneyama

11 joint publications

Teppei Okamoto

10 joint publications

Hirotake Kodama